Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations Outcomes, Complications, and Predictors of Neurologic Deficits

被引:76
作者
Starke, Robert M.
Komotar, Ricardo J.
Otten, Marc L.
Hahn, David K. [2 ]
Fischer, Laura E.
Hwang, Brian Y.
Garrett, Matthew C.
Sciacca, Robert R.
Sisti, Michael B.
Solomon, Robert A.
Lavine, Sean D. [3 ]
Connolly, E. Sander
Meyers, Philip M. [1 ,3 ]
机构
[1] Columbia Univ, Dept Neurosurg, Neurol Inst, New York, NY 10032 USA
[2] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA
[3] Columbia Univ, Dept Intervent Neuroradiol, New York, NY 10032 USA
关键词
arteriovenous malformation; complication; embolization; outcome; surgery; PREOPERATIVE EMBOLIZATION; ENDOVASCULAR TREATMENT; GRADING SYSTEM; STEREOTAXIC RADIOSURGERY; SURGICAL-MANAGEMENT; BASAL GANGLIA; BRAIN; EXPERIENCE; DETERMINANTS; SURGERY;
D O I
10.1161/STROKEAHA.108.539775
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The purpose of this study was to assess the frequency, severity, and predictors of neurological deficits after adjuvant embolization for cerebral arteriovenous malformations. Methods-From 1997 to 2006, 202 of 275 patients with arteriovenous malformation received embolization before microsurgery (n = 176) or radiosurgery (n = 26). Patients were examined before and after endovascular embolization and at clinical follow-up (mean, 43.4 +/- 34.6 months). Outcome was classified according to the modified Rankin Scale. New neurological deficits after embolization were defined as minimal (no change in overall modified Rankin Scale), moderate (modified Rankin Scale <= 2), or significant (modified Rankin Scale > 2). Results-Two hundred two patients were treated in 377 embolization procedures. There were a total of 29 new clinical deficits after embolization (8% of procedures; 14% of patients), of which 19 were moderate or significant. Postembolization deficits resolved in a significant number of patients over time (P < 0.0001). Five patients had persistent neurological deficits due to embolization (1.3% of procedures; 2.5% of patients). In multivariate analysis, the following variables significantly predicted new neurological deficit after embolization: complex arteriovenous malformation with treatment plan specifying more than one embolization procedure (OR, 2.7; 95% CI, 1.4 to 8.6), diameter < 3 cm (OR, 3.2; 95% CI, 1.2 to 9.1), diameter > 6 cm (OR, 6.2; 95% CI, 1.0 to 57.0), deep venous drainage (OR, 2.7; 95% CI, 1.1 to 6.9), or eloquent location (OR, 2.4; 95% CI, 1.0 to 5.7). These variables were weighted and used to compute an arteriovenous malformation Embolization Prognostic Risk Score for each patient. A score of 0 predicted no new deficits, a score of 1 predicted a new deficit rate of 6%, a score of 2 predicted a new deficit rate of 15%, a score of 3 predicted a new deficit rate of 21%, and a score of 4 predicted a new deficit rate of 50% (P < 0.0001). Conclusions-Small and large size, eloquent location, deep venous drainage, and complex vascular anatomy requiring multiple embolization procedures are risk factors for the development of immediate postembolization neurological deficits. Nevertheless, a significant number of patients with treatment-related neurological deficits improve over time. The low incidence of permanent neurological deficits underscores the usefulness of this technique in carefully selected patients. (Stroke. 2009; 40: 2783-2790.)
引用
收藏
页码:2783 / 2790
页数:8
相关论文
共 68 条
  • [1] Altman DG., 1996, PRACTICAL STAT MED R, V7th
  • [2] Embolization before radiosurgery reduces the obliteration rate of artericivenous malformations
    Andrade-Souza, Yuri M.
    Ramani, Meera
    Scora, Daryl
    Tsao, May N.
    terBrugge, Karel
    Schwartz, Michael L.
    [J]. NEUROSURGERY, 2007, 60 (03) : 443 - 451
  • [3] INTRACRANIAL ARTERIOVENOUS MALFORMATION - RELATIONSHIP BETWEEN CLINICAL FACTORS AND SURGICAL COMPLICATIONS
    BATJER, HH
    DEVOUS, MD
    SEIBERT, GB
    PURDY, PD
    BONTE, FJ
    [J]. NEUROSURGERY, 1989, 24 (01) : 75 - 79
  • [4] EMBOLIZATION OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS WITH BUCRYLATE - EXPERIENCE IN 46 CASES
    DEBRUN, G
    VINUELA, F
    FOX, A
    DRAKE, CG
    [J]. JOURNAL OF NEUROSURGERY, 1982, 56 (05) : 615 - 627
  • [5] Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate
    Debrun, GM
    Aletich, V
    Ausman, JI
    Charbel, F
    Dujovny, M
    [J]. NEUROSURGERY, 1997, 40 (01) : 112 - 120
  • [6] DEMERITT JS, 1995, AM J NEURORADIOL, V16, P1801
  • [7] Complications after multidisciplinary treatment of cerebral arteriovenous malformations
    Deruty, R
    PelissouGuyotat, I
    Amat, D
    Mottolese, C
    Bascoulergue, Y
    Turjman, F
    Gerard, JP
    [J]. ACTA NEUROCHIRURGICA, 1996, 138 (02) : 119 - 131
  • [8] THE COMBINED MANAGEMENT OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS - EXPERIENCE WITH 100 CASES AND REVIEW OF THE LITERATURE
    DERUTY, R
    PELISSOUGUYOTAT, I
    MOTTOLESE, C
    BASCOULERGUE, Y
    AMAT, D
    [J]. ACTA NEUROCHIRURGICA, 1993, 123 (3-4) : 101 - 112
  • [9] Duong DH, 1999, NEW ENGL J MED, V340, P1812
  • [10] Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations
    Duong, DH
    Young, WL
    Vang, MC
    Sciacca, RR
    Mast, H
    Koennecke, HC
    Hartmann, A
    Joshi, S
    Mohr, JP
    Pile-Spellman, J
    [J]. STROKE, 1998, 29 (06) : 1167 - 1176